Source: ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016



Rating:

Share or cite this content

Citations should be made in the following way:
Kiminobu Tanizawa, Tomohiro Handa, Sonoko Nagai, Akio Niimi, Tsuyoshi Oguma, Takeshi Kubo, Yutaka Ito, Kensaku Aihara, Kohei Ikezoe, Hisako Matsumoto, Toyohiro Hirai, Kazuo Chin, Michiaki Mishima. Comprehensive evaluation of airway involvement in pulmonary sarcoidosis. ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016

Member's Comments

No comment yet.

Related content which might interest you: Problems of diagnosis of pulmonary sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Evaluation of diagnostic methods in pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 539s Year: 2006 The diagnostic role of cryobiopsy in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions Year: 2013 Renal involvement in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 550s Year: 2005 Comprehensive study of the mucociliary system in patients with chronic obstructive pulmonary pathology Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases Year: 2020 Pulmonary function impairment in newly diagnosed pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001 Clinical features of combined pulmonary fibrosis and emphysema Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Dynamic bronchial obstruction in pulmonary sarcoidosis - study on 52 patients Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002 Clinical and radiological variants of fibrosis pulmonary sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Treatment of combined pulmonary fibrosis and emphysema Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 The assessment of pulmonary aspergiloma Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 The effect of pulmonary rehabilitation programme in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects Year: 2011 Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Correlation among pulmonary function tests and radiologic involvement in the monitoring of sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Clinical relevance of airway remodelling in airway diseases Source: Eur Respir J 2007; 30: 134-155 Year: 2007 Effects of lymphadenopathy on pulmonary function tests in sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 The study of pulmonary circulation in the patients with pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Assessment of cardiac involvement in patients with sarcoidosis Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011